Loading...
SI-BONE, Inc.
SIBN•NASDAQ
Healthcare
Medical - Devices
$17.60
$0.35(2.03%)
SI-BONE, Inc. (SIBN) Financial Performance & Income Statement Overview
Review SI-BONE, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
20.37%
↑ 20.37%
Operating Income Growth
24.89%
↑ 24.89%
Net Income Growth
28.67%
↑ 28.67%
Operating Cash Flow Growth
33.60%
↑ 33.60%
Operating Margin
-17.38%
↓ 17.38%
Gross Margin
79.25%
↑ 79.25%
Net Profit Margin
-15.03%
↓ 15.03%
ROE
-16.00%
↓ 16.00%
ROIC
-15.09%
↓ 15.09%
SI-BONE, Inc. (SIBN) Income Statement & Financial Overview
Review SI-BONE, Inc.'s (SIBN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $49.002M | $40.34M | $39.97M | $37.87M |
| Cost of Revenue | $10.22M | $8.44M | $8.39M | $8.002M |
| Gross Profit | $38.78M | $31.90M | $31.58M | $29.86M |
| Gross Profit Ratio | $0.79 | $0.79 | $0.79 | $0.79 |
| R&D Expenses | $3.87M | $3.99M | $4.35M | $4.34M |
| SG&A Expenses | $40.40M | $35.54M | $37.30M | $37.56M |
| Operating Expenses | $44.27M | $39.54M | $41.65M | $41.91M |
| Total Costs & Expenses | $54.50M | $47.97M | $50.05M | $49.91M |
| Interest Income | $1.78M | $1.94M | $2.02M | $2.11M |
| Interest Expense | $793000.00 | $884000.00 | $880000.00 | $881000.00 |
| Depreciation & Amortization | $1.21M | $1.08M | $992000.00 | $1.09M |
| EBITDA | -$2.49M | -$4.61M | -$7.07M | -$8.93M |
| EBITDA Ratio | -$0.05 | -$0.11 | -$0.18 | -$0.24 |
| Operating Income | -$5.49M | -$7.63M | -$10.08M | -$12.04M |
| Operating Income Ratio | -$0.11 | -$0.19 | -$0.25 | -$0.32 |
| Other Income/Expenses (Net) | $999000.00 | $1.06M | $1.14M | $1.14M |
| Income Before Tax | -$4.50M | -$6.58M | -$8.94M | -$10.90M |
| Income Before Tax Ratio | -$0.09 | -$0.16 | -$0.22 | -$0.29 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.05M |
| Net Income | -$4.50M | -$6.58M | -$8.94M | -$10.90M |
| Net Income Ratio | -$0.09 | -$0.16 | -$0.22 | -$0.29 |
| EPS | -$0.11 | -$0.16 | -$0.22 | -$0.27 |
| Diluted EPS | -$0.11 | -$0.16 | -$0.22 | -$0.27 |
| Weighted Avg Shares Outstanding | $41.99M | $41.72M | $41.32M | $40.93M |
| Weighted Avg Shares Outstanding (Diluted) | $41.99M | $41.72M | $41.32M | $40.93M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan